Cite

HARVARD Citation

    Bar-Or, A. et al. (2022). Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study. Multiple sclerosis. pp. 910-924. [Online]. 
  
Back to record